Temat: "Antirheumatic Agents" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Effect of hydroxychloroquine blood concentration on the efficacy and ocular toxicity of systemic lupus erythematosus.
Autorzy:: Liu PC; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Luo SL; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Lv MN; The First Clinical Medical College of Nanchang University, Nanchang, China.
Wang Y; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Li JB; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yu SJ; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Wu R; Department of Rheumatology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7674. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/adverse effects
Lupus Erythematosus, Systemic*/drug therapy
Humans ; Hydroxychloroquine/adverse effects ; Tandem Mass Spectrometry ; Retrospective Studies ; Toxic Optic Neuropathy/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Molecular Profiling of Axial Spondyloarthritis Patients Reveals an Association between Innate and Adaptive Cell Populations and Therapeutic Response to Tumor Necrosis Factor Inhibitors.
Autorzy:: Sobral D; Applied Molecular Biosciences Unit, Life Sciences Department, Sciences and Technology School, NOVA University of Lisbon, 2829-516 Caparica, Portugal.
Fernandes AF; Instituto de Tecnologia Química e Biológica António Xavier, Nova University of Lisbon, Av. Da República, 2780-157 Oeiras, Portugal.
Bernardes M; Department of Medicine, Faculty of Medicine, University of Porto, 4099-002 Porto, Portugal.; Rheumatology Department, Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal.
Pinto P; Rheumatology Department, Centro Hospitalar de Vila Nova de Gaia/Espinho, 4434-502 Vila Nova de Gaia, Portugal.
Santos H; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.; Portuguese Institute of Rheumatology, 1050-034 Lisbon, Portugal.
Lagoas-Gomes J; Rheumatology Department, Centro Hospitalar do Tâmega e Sousa, Hospital Padre Américo, 4560-136 Penafiel, Portugal.
Tavares-Costa J; Rheumatology Department, Unidade Local de Saúde do Alto Minho, 4990-078 Ponte de Lima, Portugal.
Silva JAP; I.CBR-Institute for Clinical and Biomedical Research, Faculty of Medicine, University of Coimbra, 3000-548 Coimbra, Portugal.; Rheumatology Department, Centro Hospitalar e Universitário de Coimbra, 3004-561 Coimbra, Portugal.
Dias JM; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.; Rheumatology Department, Centro Hospitalar Médio Tejo, 2350-754 Torres Novas, Portugal.
Bernardo A; Rheumatology Department, Centro Hospitalar e Universitário de São João, 4200-319 Porto, Portugal.
Gaillard JC; Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SPI, F-30200 Bagnols-sur-Cèze, France.
Armengaud J; Département Médicaments et Technologies pour la Santé (DMTS), Université Paris-Saclay, CEA, INRAE, SPI, F-30200 Bagnols-sur-Cèze, France.
Benes V; EMBL Genomics Core Facility, Meyerhofstr. 1, D-69117 Heidelberg, Germany.
Domingues L; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.; Escola Superior de Saúde, Instituto Politécnico de Setúbal, 2910-761 Setúbal, Portugal.
Maia S; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.
Branco JC; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.; Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas-Moniz, 1349-019 Lisbon, Portugal.
Coelho AV; Instituto de Tecnologia Química e Biológica António Xavier, Nova University of Lisbon, Av. Da República, 2780-157 Oeiras, Portugal.
Pimentel-Santos FM; NOVA Medical Research, NOVA Medical School, NOVA University of Lisbon, 1169-056 Lisbon, Portugal.; Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas-Moniz, 1349-019 Lisbon, Portugal.; Pokaż więcej
Źródło:: Biomolecules [Biomolecules] 2024 Mar 21; Vol. 14 (3). Date of Electronic Publication: 2024 Mar 21.
Typ publikacji:: Journal Article
MeSH Terms:: Spondylitis, Ankylosing*
Antirheumatic Agents*/therapeutic use
Axial Spondyloarthritis*
Humans ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Adalimumab/therapeutic use ; Tumor Necrosis Factor-alpha ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Biomarker combination predicting imminent relapse after discontinuation of biological drugs in patients with rheumatoid arthritis in remission.
Autorzy:: Sakashita E; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan.
Nagatani K; Department of Medicine, Division of Rheumatology and Clinical Immunology, Jichi Medical University School of Medicine, Tochigi, Japan.
Endo H; Department of Biochemistry, Jichi Medical University School of Medicine, Tochigi, Japan.
Minota S; Department of Medicine, Division of Rheumatology and Clinical Immunology, Jichi Medical University School of Medicine, Tochigi, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 21; Vol. 19 (3), pp. e0299450. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Arthritis, Rheumatoid*/drug therapy
Antirheumatic Agents*/therapeutic use
Biological Products*/therapeutic use
Humans ; Matrix Metalloproteinase 3 ; Interleukin-6/therapeutic use ; Biomarkers ; Chronic Disease ; Recurrence ; Remission Induction ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Changes in Inflammatory Cytokines in Responders and Non-Responders to TNFα Inhibitor and IL-17A Inhibitor: A Study Examining Psoriatic Arthritis Patients.
Autorzy:: Skougaard M; The Parker Institute, Copenhagen University Hospital Bispebjerg and Frederiksberg, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.; Copenhagen Center for Translational Research, Copenhagen University Hospital Bispebjerg and Frederiksberg, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark.; Department of Clinical Immunology, Aarhus University Hospital, Palle Juul-Jensens Boulevard 99, 8200 Aarhus, Denmark.
Søndergaard MF; Copenhagen Center for Translational Research, Copenhagen University Hospital Bispebjerg and Frederiksberg, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark.
Ditlev SB; Copenhagen Center for Translational Research, Copenhagen University Hospital Bispebjerg and Frederiksberg, Bispebjerg Bakke 23, 2400 Copenhagen, Denmark.
Kristensen LE; The Parker Institute, Copenhagen University Hospital Bispebjerg and Frederiksberg, Nordre Fasanvej 57, 2000 Frederiksberg, Denmark.; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200 Copenhagen, Denmark.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 05; Vol. 25 (5). Date of Electronic Publication: 2024 Mar 05.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis, Psoriatic*/drug therapy
Humans ; Biomarkers ; Cytokines/antagonists & inhibitors ; Cytokines/immunology ; Cytokines/metabolism ; Interleukin Inhibitors/pharmacology ; Interleukin Inhibitors/therapeutic use ; Interleukin-17/antagonists & inhibitors ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Potential Rheumatoid Arthritis-Associated Interstitial Lung Disease Treatment and Computational Approach for Future Drug Development.
Autorzy:: Jeong E; Department of Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Hong H; Yale College, Yale University, New Haven, CT 06520, USA.; Department of Clinical Pharmacology and Therapeutics, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.
Lee YA; Division of Rheumatology, Department of Internal Medicine, Kyung Hee University Hospital, Seoul 02447, Republic of Korea.
Kim KS; Department of Medicine, College of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.; Department of Clinical Pharmacology and Therapeutics, School of Medicine, Kyung Hee University, Seoul 02447, Republic of Korea.; East-West Bone & Joint Disease Research Institute, Kyung Hee University Hospital at Gangdong, Seoul 05278, Republic of Korea.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 26; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 26.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Lung Diseases, Interstitial*/etiology
Arthritis, Rheumatoid*/drug therapy
Idiopathic Pulmonary Fibrosis*/drug therapy
Antirheumatic Agents*/therapeutic use
Humans ; Inflammation/drug therapy ; Immunosuppressive Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: A 40-Year-Old Man with a 7-Year History of Polyarthritis and a Late Diagnosis of Whipple Disease: A Journey to Resolve the Mystery.
Autorzy:: Aulakh G; Department of Internal Medicine, Jersey City Medical Center, Jersey City, NJ, USA.
Lewis R; Department of Internal Medicine, Jersey City Medical Center, Jersey City, NJ, USA.
Singh A; Department of Internal Medicine, Government Medical College, Medical Enclave, Amritsar, India.
Marian V; Department of Internal Medicine, Jersey City Medical Center, Jersey City, NJ, USA.; Pokaż więcej
Źródło:: The American journal of case reports [Am J Case Rep] 2024 Feb 25; Vol. 25, pp. e942896. Date of Electronic Publication: 2024 Feb 25.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis*/diagnosis
Whipple Disease*/diagnosis
Whipple Disease*/drug therapy
Whipple Disease*/complications
Adult ; Humans ; Male ; Anti-Bacterial Agents/therapeutic use ; Delayed Diagnosis ; Fever/complications ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Burden of non-serious infections during biological use for rheumatoid arthritis.
Autorzy:: Bergmans B; Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
Jessurun N; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
van Lint J; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.
Murk JL; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.; Microvida, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.
van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy,-Epidemiology & -Economics, Groningen, The Netherlands.
de Vries E; Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands.; Laboratory of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Feb 20; Vol. 19 (2), pp. e0296821. Date of Electronic Publication: 2024 Feb 20 (Print Publication: 2024).
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Arthritis, Rheumatoid*/drug therapy
Antirheumatic Agents*/adverse effects
Adult ; Humans ; Quality of Life ; Biological Factors/therapeutic use ; Health Personnel ; Patients

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Population pharmacokinetics and exposure-response analyses for efficacy and safety of upadacitinib in patients with axial spondyloarthritis.
Autorzy:: Bhatnagar S; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA.
Eckert D; Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
Stodtmann S; Clinical Pharmacology, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen am Rhein, Germany.
Song IH; Immunology Clinical Development, AbbVie, North Chicago, Illinois, USA.
Wung P; Immunology Clinical Development, AbbVie, North Chicago, Illinois, USA.
Liu W; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA.
Mohamed MF; Clinical Pharmacology, AbbVie, North Chicago, Illinois, USA.; Pokaż więcej
Źródło:: Clinical and translational science [Clin Transl Sci] 2024 Feb; Vol. 17 (2), pp. e13733.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Non-Radiographic Axial Spondyloarthritis*
Spondylitis, Ankylosing*/drug therapy
Spondylarthritis*/drug therapy
Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Detection of novel drug-adverse drug reaction signals in rheumatoid arthritis and ankylosing spondylitis: analysis of Korean real-world biologics registry data.
Autorzy:: Kwon M; Department of Internal Medicine, School of Medicine, Konyang University, Daejeon, South Korea.; Konyang University Myunggok Medical Research Institute, Daejeon, South Korea.; Department of Biomedical Informatics, School of Medicine, Konyang University, Daejeon, South Korea.
Joung CI; Department of Internal Medicine, School of Medicine, Konyang University, Daejeon, South Korea.
Shin H; Healthcare Data Science Centre, Konyang University Hospital, Daejeon, South Korea.
Lee CC; Department of Biomedical Informatics, School of Medicine, Konyang University, Daejeon, South Korea.
Song YS; Department of Pathology, School of Medicine, Konyang University, Daejeon, South Korea.
Lee YJ; Department of Biomedical Informatics, School of Medicine, Konyang University, Daejeon, South Korea.; Department of Rehabilitation Medicine, School of Medicine, Konyang University, Daejeon, South Korea.
Kang S; Department of Internal Medicine, School of Medicine, Konyang University, Daejeon, South Korea.
Kim JY; Department of Biomedical Informatics, School of Medicine, Konyang University, Daejeon, South Korea.; Healthcare Data Science Centre, Konyang University Hospital, Daejeon, South Korea.; Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Konyang University, Daejeon, South Korea.
Lee S; Department of Computer Engineering, Gachon University, (13120) 1342 Seongnamdaero, Sujeong-gu, Seongnam-si, Gyeonggi-do, South Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Feb 01; Vol. 14 (1), pp. 2660. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Spondylitis, Ankylosing*/drug therapy
Spondylitis, Ankylosing*/chemically induced
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/chemically induced
Antirheumatic Agents*/adverse effects
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Biological Products*/adverse effects
Humans ; Pharmaceutical Preparations ; Routinely Collected Health Data ; Registries ; Republic of Korea/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: A study to determine the effect of hydroxychloroquine (HCQ) on central corneal thickness (CCT) in patients with rheumatoid arthritis (RA).
Autorzy:: Jaichander RC; Department of Ophthalmology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.
Thomas RK; Department of Ophthalmology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.
Shobha V; Department of Immunology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.; Pokaż więcej
Źródło:: Indian journal of ophthalmology [Indian J Ophthalmol] 2024 Feb 01; Vol. 72 (2), pp. 270-274. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/drug therapy
Eye Diseases*
Humans ; Adult ; Hydroxychloroquine/therapeutic use ; Cross-Sectional Studies ; Cornea

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients.
Autorzy:: Goutakoli P; Laboratory of Rheumatology, Autoimmunity and Inflammation, Medical School, University of Crete, 71003 Heraklion, Greece.
Papadaki G; Laboratory of Rheumatology, Autoimmunity and Inflammation, Medical School, University of Crete, 71003 Heraklion, Greece.
Repa A; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.
Avgoustidis N; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.
Kalogiannaki E; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.
Flouri I; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.
Bertsias A; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.
Zoidakis J; Department of Biotechnology, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
Samiotaki M; Protein Chemistry Facility, Biomedical Sciences Research Center 'Alexander Fleming', 16672 Athens, Greece.
Bertsias G; Laboratory of Rheumatology, Autoimmunity and Inflammation, Medical School, University of Crete, 71003 Heraklion, Greece.; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.; Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece.
Semitekolou M; Laboratory of Rheumatology, Autoimmunity and Inflammation, Medical School, University of Crete, 71003 Heraklion, Greece.; Laboratory of Cellular Immunology Division of Basic Research, Biomedical Research Foundation of the Academy of Athens, 11527 Athens, Greece.
Verginis P; Laboratory of Immune Regulation and Tolerance, Division of Basic Sciences, Medical School, University of Crete, 71003 Heraklion, Greece.
Sidiropoulos P; Laboratory of Rheumatology, Autoimmunity and Inflammation, Medical School, University of Crete, 71003 Heraklion, Greece.; Rheumatology and Clinical Immunology, University Hospital of Heraklion, 71003 Heraklion, Greece.; Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology Hellas (FORTH), 70013 Heraklion, Greece.; Pokaż więcej
Źródło:: Cells [Cells] 2023 Dec 09; Vol. 12 (24). Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antirheumatic Agents*/pharmacology
Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*
Humans ; Abatacept/pharmacology ; Abatacept/therapeutic use ; Inflammation Mediators ; Myeloid Cells

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Retention rate of subcutaneous TNF inhibitors in axial spondyloarthritis in a multicentre study from the RIC-FRANCE network.
Autorzy:: Larid G; LITEC, Université de Poitiers, CHU Poitiers, 86000, Poitiers, France. .
Baudens G; Private Practice, Valenciennes, France.
Tiemdjo-Djimaffo G; CHU Poitiers, Poitiers, France.
Coquerelle P; Bethune Hospital Center, Bethune, France.
Goeb V; University Hospital of Amiens-Picardie, Amiens, France.
Guyot MH; Hôpital Victor Provo, Hospital of Roubaix, Roubaix, France.
Marguerie L; Fondation Hopale, Berck-sur-Mer, France.
Maury F; Private Practice, Beuvry, France.
Veillard E; Private Practice, Saint Malo, France.
Houvenagel E; Hôpital Saint Philibert, Hospital of Lomme, Lomme, France.
Salmon JH; Centre Hospitalier Universitaire de Reims, Reims, France.
Flipo RM; CHU Lille, Lille, France.
Gervais E; LITEC, Université de Poitiers, CHU Poitiers, 86000, Poitiers, France.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 16; Vol. 14 (1), pp. 1374. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:: Observational Study; Multicenter Study; Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Axial Spondyloarthritis*
Spondylarthritis*/drug therapy
Female ; Humans ; Male ; Adalimumab/therapeutic use ; Certolizumab Pegol/therapeutic use ; Etanercept/therapeutic use ; France ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Tumor Necrosis Factor-alpha/therapeutic use ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Latent and active tuberculosis development in patients with rheumatoid arthritis receiving biologic disease-modifying antirheumatic drugs: A single-center prospective study.
Autorzy:: Hai BB; Centre of Rheumatology, Bach Mai Hospital, Hanoi, Vietnam.
Anh TL; Department of Rheumatology and Endocrinology, Thanh Hoa Hospital, Thanh Hoa, Vietnam.
Thi Thu PN; Pharmacy Faculty, Hai Phong University of Medicine and Pharmacy, Hai Phong, Vietnam.; Department of Pharmacy, Hai Phong International Hospital, Hai Phong, Vietnam.
Van HN; Centre of Rheumatology, Bach Mai Hospital, Hanoi, Vietnam.; Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam.
Van GV; Department of Internal Medicine, Hanoi Medical University, Hanoi, Vietnam.
Van DH; Department of Internal Medicine, Hai Phong International Hospital, Hai Phong, Vietnam.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Jan 11; Vol. 19 (1), pp. e0295048. Date of Electronic Publication: 2024 Jan 11 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/complications
Arthritis, Rheumatoid*/drug therapy
Arthritis, Rheumatoid*/epidemiology
Biological Products*/therapeutic use
Latent Tuberculosis*/diagnosis
Latent Tuberculosis*/epidemiology
Latent Tuberculosis*/drug therapy
Tuberculosis*/complications
Tuberculosis*/epidemiology
Tuberculosis*/diagnosis
Humans ; Biological Factors/therapeutic use ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data.
Autorzy:: Milatz F; Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Charitéplatz 1, 10117, Berlin, Germany. .
Albrecht K; Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Charitéplatz 1, 10117, Berlin, Germany.
Minden K; Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Charitéplatz 1, 10117, Berlin, Germany.; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Marschall U; Department Medicine and Health Services Research, BARMER Institute for Health System Research, Wuppertal, Germany.
Klotsche J; Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Charitéplatz 1, 10117, Berlin, Germany.; Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, all Germany, Berlin, Germany.
Callhoff J; Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum, a Leibniz Institute, Charitéplatz 1, 10117, Berlin, Germany.; Institute for Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, all Germany, Berlin, Germany.; Pokaż więcej
Źródło:: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Jan 05; Vol. 22 (1), pp. 10. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Arthritis, Juvenile*/drug therapy
Arthritis, Juvenile*/epidemiology
Antirheumatic Agents*/therapeutic use
Female ; Male ; Humans ; Adolescent ; Young Adult ; Aged ; Child ; Adult ; Comorbidity ; Insurance, Health ; Emotions ; Anxiety

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Prospective study to characterize adalimumab exposure in pediatric patients with rheumatic diseases.
Autorzy:: Welzel T; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland. .; Division of Pediatric Rheumatology, Department of Pediatrics and Autoinflammation Reference Centre Tuebingen (arcT), University Hospital Tuebingen, Tuebingen, Germany. .; Pediatric Rheumatology, University Children's Hospital Basel, University of Basel, Basel, Switzerland. .; Pediatric Research Center, University Children's Hospital Basel, University of Basel, Basel, Switzerland. .
Golhen K; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Atkinson A; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.; Pediatric Research Center, University Children's Hospital Basel, University of Basel, Basel, Switzerland.; Division of Infectious Diseases, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
Gotta V; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Ternant D; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.; Université de Tours, service de pharmacologie médicale, Tours France, Université de Tours, EA 4245 T2I, Tours, France.
Kuemmerle-Deschner JB; Division of Pediatric Rheumatology, Department of Pediatrics and Autoinflammation Reference Centre Tuebingen (arcT), University Hospital Tuebingen, Tuebingen, Germany.
Michler C; Division of Pediatric Rheumatology, Department of Pediatrics and Autoinflammation Reference Centre Tuebingen (arcT), University Hospital Tuebingen, Tuebingen, Germany.
Koch G; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
van den Anker JN; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Pfister M; Pediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.
Woerner A; Pediatric Rheumatology, University Children's Hospital Basel, University of Basel, Basel, Switzerland.; Pokaż więcej
Źródło:: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2024 Jan 02; Vol. 22 (1), pp. 5. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/adverse effects
Arthritis, Rheumatoid*/drug therapy
Female ; Humans ; Child ; Adalimumab/adverse effects ; Methotrexate/adverse effects ; Prospective Studies ; Antibodies, Monoclonal, Humanized/therapeutic use ; Treatment Outcome ; Drug Therapy, Combination

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report.
Autorzy:: Miyamoto Y; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Kawasoe C; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Ito K; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Oguri N; Department of Diagnostic Pathology, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Murashima T; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Kamibeppu T; Section of Urology, Koga General Hospital, Miyazaki, Japan.
Nagai T; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Takamori H; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Kamimura T; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Mukai S; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. syoichiro_.
Sato Y; Department of Diagnostic Pathology, Faculty of Medicine, Miyazaki University Hospital, Miyazaki, Japan.
Kamoto T; Department of Urology, Faculty of Medicine, Miyazaki University Hospital, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Dec 22; Vol. 17 (1), pp. 524. Date of Electronic Publication: 2023 Dec 22.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Carcinoma, Renal Cell*/drug therapy
Carcinoma, Renal Cell*/complications
Epstein-Barr Virus Infections*
Kidney Neoplasms*/drug therapy
Kidney Neoplasms*/complications
Lymphoproliferative Disorders*/chemically induced
Female ; Humans ; Middle Aged ; Follow-Up Studies ; Liver/pathology ; Lung/pathology ; Methotrexate/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: The Effects of Periodontal Treatment on Rheumatoid Arthritis and of Anti-Rheumatic Drugs on Periodontitis: A Systematic Review.
Autorzy:: Inchingolo F; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Inchingolo AM; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Avantario P; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Settanni V; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Fatone MC; PTA Trani-ASL BT, Viale Padre Pio, 76125 Trani, Italy.
Piras F; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Di Venere D; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Inchingolo AD; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.
Palermo A; College of Medicine and Dentistry, Birmingham B4 6BN, UK.
Dipalma G; Department of Interdisciplinary Medicine, University of Bari 'Aldo Moro', 70124 Bari, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 07; Vol. 24 (24). Date of Electronic Publication: 2023 Dec 07.
Typ publikacji:: Systematic Review; Journal Article; Review
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Periodontitis*/therapy
Arthritis, Rheumatoid*
Humans ; Rheumatoid Factor ; Cytokines

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Real-world treatment patterns and healthcare costs in patients with psoriasis taking systemic oral or biologic therapies.
Autorzy:: Thai S; Bristol Myers Squibb, Princeton, NJ, USA.; Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Zhuo J; Bristol Myers Squibb, Princeton, NJ, USA.
Zhong Y; Bristol Myers Squibb, Princeton, NJ, USA.
Xia Q; Bristol Myers Squibb, Princeton, NJ, USA.
Chen X; Bristol Myers Squibb, Princeton, NJ, USA.
Bao Y; Bristol Myers Squibb, Princeton, NJ, USA.
Dhanda D; Bristol Myers Squibb, Princeton, NJ, USA.
Priya L; Mu Sigma, Bengaluru, India.
Wu JJ; Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA.; Pokaż więcej
Źródło:: The Journal of dermatological treatment [J Dermatolog Treat] 2023 Dec; Vol. 34 (1), pp. 2176708.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Psoriasis*/drug therapy
Biological Products*
Humans ; Aged ; United States ; Retrospective Studies ; Medicare ; Health Care Costs ; Biological Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Real-world retention rates of biologics in patients with rheumatoid arthritis.
Autorzy:: Takami K; Department of Orthopaedic Surgery, Nippon Life Hospital, 2-1-54 Enokojima, Nishi-ku, Osaka, 550-0006, Japan. .; Department of Rheumatology, Japan Community Healthcare Organization Osaka Hospital, Osaka, Japan. .
Tsuji S; Department of Orthopaedic Surgery, Nippon Life Hospital, 2-1-54 Enokojima, Nishi-ku, Osaka, 550-0006, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 01; Vol. 13 (1), pp. 21170. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:: Journal Article
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Biological Products*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Humans ; Treatment Outcome ; Etanercept/therapeutic use ; Adalimumab/therapeutic use ; Infliximab/therapeutic use ; Abatacept/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: AZD9567 versus prednisolone in patients with active rheumatoid arthritis: A phase IIa, randomized, double-blind, efficacy, and safety study.
Autorzy:: van Laar JM; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Lei A; Patient Safety BioPharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain.
Safy-Khan M; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.
Almquist J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Belfield G; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Edman K; Mechanistic and Structural Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Angermann BR; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Dillmann I; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Berntsson P; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Etal D; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Dainty I; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.
Nemes S; Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Prothon S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.
Samuelsson S; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Svanberg P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Keen C; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Pokaż więcej
Corporate Authors:: SEMRA study group
Źródło:: Clinical and translational science [Clin Transl Sci] 2023 Dec; Vol. 16 (12), pp. 2494-2506. Date of Electronic Publication: 2023 Oct 23.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antirheumatic Agents*/therapeutic use
Arthritis, Rheumatoid*/drug therapy
Humans ; Prednisolone/adverse effects ; Treatment Outcome ; Anti-Inflammatory Agents/therapeutic use ; Double-Blind Method ; Methotrexate/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Antirheumatic Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji